Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results Proactive Investors (Australia) 4d
The Small Cap Wrap: Actinogen Medical targets Alzheimer’s treatment gap; Percheron Phase II progress supports Edison’s 5.5-cent valuation Proactive Investors (Australia) 4d
Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market Proactive Investors (Australia) 5d
Actinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI Proactive Investors (US) 01:08 Sat, 01 Aug
ASIC reaches auditors and a new offshore vehicle in a$1.1 Billion super collapse Finance Magnates 6d ASIC Australian Real Estate Australia All sources
Woodside Energy to exit Trinidad and Tobago with Calypso stake sale to BP Proactive Investors (Australia) 3d Trinidad and Tobago Energy and Utilities Caribbean All sources
Shares soar to record highs as oil dives on peace hopes The North West Star 4d Australia Iran Middle East All sources
Mining giant Glencore looks beyond London with secondary ASX listing OilPrice.com 3d Australia South Pacific Energy and Utilities All sources
